Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Makers of Sophia the robot plan mass rollout amid pandemic

Published 2021-01-24, 08:13 p/m
Updated 2021-01-24, 10:48 p/m
© Reuters. Humanoid robots are developed in Hanson Robotics lab in Hong Kong

By Michelle Hennessy

HONG KONG (Reuters) - "Social robots like me can take care of the sick or elderly," Sophia says as she conducts a tour of her lab in Hong Kong. "I can help communicate, give therapy and provide social stimulation, even in difficult situations."

Since being unveiled in 2016, Sophia - a humanoid robot - has gone viral. Now the company behind her has a new vision: to mass-produce robots by the end of the year.

Hanson Robotics, based in Hong Kong, said four models, including Sophia, would start rolling out of factories in the first half of 2021, just as researchers predict the pandemic will open new opportunities for the robotics industry.

"The world of COVID-19 is going to need more and more automation to keep people safe," founder and chief executive David Hanson said, standing surrounded by robot heads in his lab.

Hanson believes robotic solutions to the pandemic are not limited to healthcare, but could assist customers in industries such as retail and airlines too.

"Sophia and Hanson robots are unique by being so human-like," he added. "That can be so useful during these times where people are terribly lonely and socially isolated."

Hanson said he aims to sell "thousands" of robots in 2021, both large and small, without providing a specific number.

Social robotics professor Johan Hoorn, whose research has included work with Sophia, said that although the technology is still in relative infancy, the pandemic could accelerate a relationship between humans and robots.

"I can infer the pandemic will actually help us get robots earlier in the market because people start to realise that there is no other way," said Hoorn, of Hong Kong Polytechnic University.

Hanson Robotics is launching a robot this year called Grace, developed for the healthcare sector.

Products from other big players in the industry are helping fight the pandemic as well. SoftBank Robotics' Pepper robot was deployed to detect people who weren't wearing masks. In China, robotics company CloudMinds helped set up a robot-run field hospital during the coronavirus outbreak in Wuhan. 

The use of robots was on the rise before the pandemic. According to a report by the International Federation of Robotics, worldwide sales of professional-service robots had already jumped 32% to $11.2 billion between 2018 and 2019.

Some humans might be wary of putting robots in such sensitive roles. When asked whether people should fear robots, Sophia had an answer ready.

© Reuters. Humanoid robots are developed in Hanson Robotics lab in Hong Kong

"Someone said 'we have nothing to fear but fear itself'," the robot mused. "What did he know?"

Latest comments

yikes
😬
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.